Search for: "Wyeth Pharmaceuticals" Results 561 - 580 of 976
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs)   Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
26 Aug 2009, 6:12 am
F. of L. files antitrust suit against Merck, alleging fraudulent procurement of a patent, improper listing of patent in Orange Book (Patent Docs) Singulair (Montelukast) – US: Merck get injunction preventing Teva from selling generic Montelukast: Merck Sharp & Dohme Pharmaceuticals SRL v Teva Pharmaceuticals USA (The IP Factor) (IP Watchdog) (SmartBrief) (SmartBrief) (GenericsWeb)   [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs)   Products Cepham… [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic companies… [read post]
21 May 2007, 8:03 am
The appeal by the pharmaceutical company, Wyeth, involves a challenge to a separate labeling requirement imposed by the state of Vermont on Wyeth's anti-nausea drug, Phenergan. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts - same patent: a… [read post]
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Effexor (Venlafaxine) – US: Sandoz loses motion for interlocutory appeal in Effexor patent suit with Wyeth (Patent Docs) EpiPen Auto-Injector (Epinephrine) – US: Patent infringement complaint following a Paragraph IV certification: King Pharmaceuticals, Inc. et al. v. [read post]
3 Feb 2009, 7:22 am
According to the ATRA website, here are some of the members: The American Medical Association, State Farm Insurance, Johnson & Johnson, Medical Mutual Insurance, Pfizer, Physician Insurers Association of America, Pharmaceutical Reasearch & Manufacturers of America, American Trucking Associations, and Wyeth, among others. [read post]
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs)   General Blockbusters and other strategies (IP Think Tank) AU - TRIPS, Pharmaceuticals and Manufacture for Export - IP Think Tank Podcast (IP Think Tank) Germany: Open fight on biotechnology, patents, and CIIs (IP Jur) US - It’s not an invention if you use conventional techniques to make it (Patent Baristas) US - Debate on creating a regulatory pathway for approval of follow-on biologics (FOB) (Patent Baristas)… [read post]